Boston Scientific (NYSE:BSX) today announced the first patient treated with its Seismiq IVL system in the ELEGANCE registry.

The strategic investment will support UroMems' clinical trials and help prepare for the commercial launch of its UroActive ...

Owens & Minor announced today that it appointed Marc Rottink as its new chief operating officer (COO), effective immediately.

Epineuron said FDA clearance marks a significant expansion of its portfolio. It also expands the commercial footprint of its ...

Andera Partners said today that it led a $20 million Series D financing round for urology-focused medical device maker ...

Orchestra BioMed (Nasdaq:OBIO) announced updated expectations for the timeline of its BACKBEAT cardiac pacing clinical trial.

Siemens Healthineers announced today that the FDA cleared six new systems within its Artis interventional imaging portfolio.

Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and ...

Orchestra BioMed (Nasdaq:OBIO) announced today that it secured $35 million in total funding through partnerships with ...

Johnson & Johnson (NYSE:JNJ) today announced results from the first clinical study of its investigational Ottava surgical ...

Stryker reported first-quarter results that missed the Wall Street analyst consensus due to a major cyberattack by ...

Noctrix Health developed and manufactures a novel non-invasive, wearable therapy to treat drug-refractory Restless Leg ...